DiaMedica Therapeutics Inc
NASDAQ:DMAC

Watchlist Manager
DiaMedica Therapeutics Inc Logo
DiaMedica Therapeutics Inc
NASDAQ:DMAC
Watchlist
Price: 8.47 USD 1.44% Market Closed
Market Cap: 441.1m USD

Intrinsic Value

There is not enough data to reliably calculate the intrinsic value of DMAC.

The Intrinsic Value is calculated as the average of DCF and Relative values:

DMAC Intrinsic Value
Not Available
Base Case Scenario
Compare DMAC to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about DMAC?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
DiaMedica Therapeutics Inc

Current Assets 56.2m
Cash & Short-Term Investments 55.3m
Receivables 260k
Other Current Assets 645k
Non-Current Assets 824k
PP&E 368k
Other Non-Current Assets 456k
Current Liabilities 5.3m
Accounts Payable 1.9m
Accrued Liabilities 3.3m
Other Current Liabilities 10k
Non-Current Liabilities 157k
Long-Term Debt 7k
Other Non-Current Liabilities 150k
Efficiency

Free Cash Flow Analysis
DiaMedica Therapeutics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
DiaMedica Therapeutics Inc

Revenue
0 USD
Operating Expenses
-33.6m USD
Operating Income
-33.6m USD
Other Expenses
1.7m USD
Net Income
-31.9m USD
Fundamental Scores

DMAC Profitability Score
Profitability Due Diligence

DiaMedica Therapeutics Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Exceptional 3Y Average ROIC
Low 3Y Average Gross Margin
Low 3Y Average Net Margin
Low 3Y Average Operating Margin
hidden
Profitability
Score

DiaMedica Therapeutics Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

DMAC Solvency Score
Solvency Due Diligence

DiaMedica Therapeutics Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Negative Net Debt
hidden
Solvency
Score

DiaMedica Therapeutics Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

DMAC Price Targets Summary
DiaMedica Therapeutics Inc

Wall Street analysts forecast DMAC stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for DMAC is 15.81 USD with a low forecast of 11.11 USD and a high forecast of 26.25 USD.

Lowest
Price Target
11.11 USD
31% Upside
Average
Price Target
15.81 USD
87% Upside
Highest
Price Target
26.25 USD
210% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

DiaMedica Therapeutics Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for DMAC is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
No dividends
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

DMAC Insider Trading
Buy and sell transactions by insiders